LSTM launches collaborative project to develop, evaluate new tools for malaria control

LSTM has launched a collaborative project to develop and evaluate new tools to control the spread of malaria in Africa. AvecNet is a five year, -12 million project involving sixteen partners in Africa and Europe, funded by the European Union's Seventh Framework programme.

Because malaria is transmitted by mosquitoes, their effective control is essential to combating the disease. Wide scale use of insecticides on bednets and in interior spraying programmes has dramatically reduced transmission but continued success is dependent on a very limited range of insecticides and other tools.

AvecNet aims to secure the continued effectiveness of these methods into the future by developing and evaluating new insecticides and techniques that will overcome the growing threat of insecticide resistance, as well as designing new tools and interventions to target the mosquitoes that currently evade these control methods. The project also aims to increase existing knowledge about the biology and behaviour of mosquitoes to enable more effective control as urbanisation and other environmental factors alter the balance in this continuing fight against an evolving and formidable opponent.

Dr Hilary Ranson, Head of the Vector Group at LSTM and leader of AvecNet, said: "We need to secure the viability of existing malaria control programmes and expand their scope and reach by developing new methods and tools based upon a vastly increased understanding of how mosquitoes behave and react in different environments.

"We will also rigorously field test existing and prototype tools and techniques to both inform their further development and refinement and to add to the knowledge base from which we can develop further tools and interventions.

"By increasing research capacity in Africa and Europe and uniting people with skills in lots of different fields we are going to generate the momentum to achieve what we hope will be a number of significant breakthroughs in malaria control."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A promising new strategy for malaria drug development